Bone Biologics: Funding, Investors & Team (Oct 2026)
Bone Biologics, a company headquartered in Burlington, MA, is publicly traded and specializes in the development and promotion of orthobiologic products. The company's main focus is on NELL-1, a proprietary platform technology consisting of a synthetic human protein growth factor crucial for the proper development of bones.
Bone Biologics has raised $10.1M across 2 funding rounds on record, the most recent an undisclosed round of $5.0M announced in Jun 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Bone Biologics Company Profile and Key Stats
Latest funding round on record: Jun 2025.
Bone Biologics Funding Rounds
Bone Biologics raised $5.1M in a Post-IPO Equity announced in Oct 2022.
2.7 years later, an undisclosed round of $5.0M was announced in Jun 2025.
Bone Biologics Founders and Leadership Team
No contact details are on record for this team yet.
Bone Biologics Funding Compared to Other Biotechnology Startups
Bone Biologics' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bone Biologics in Biotechnology and Burlington
Companies Similar to Bone Biologics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Bone Biologics Funding FAQs
What does Bone Biologics do?
Bone Biologics, a company headquartered in Burlington, MA, is publicly traded and specializes in the development and promotion of orthobiologic products. The company's main focus is on NELL-1, a proprietary platform technology consisting of a synthetic human protein growth factor crucial for the proper development of bones.
How much funding has Bone Biologics raised?
Bone Biologics has raised $10.1M across 2 rounds on record. The most recent is an undisclosed round of $5.0M announced in Jun 2025.
When did Bone Biologics last raise funding?
Bone Biologics' most recent funding round on record is an undisclosed round of $5.0M, announced in Jun 2025.
Who founded Bone Biologics?
FundedIQ lists Michael Schuler (Founder) at Bone Biologics.
Where is Bone Biologics headquartered?
Bone Biologics is based in Burlington, Massachusetts, United States.
How many employees does Bone Biologics have?
Bone Biologics is in the 11-50 employee band.
How does Bone Biologics' funding compare to other Biotechnology startups?
Bone Biologics' latest round of $5.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Bone Biologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bone Biologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.